Uploaded May 2026 | Updated September 2026, 2 weeks ago
Capital deficiency kills biotechs. This is how to avoid it, according to David Sinclair:
Peter H. Diamandis
|
David Sinclair on Biotech Investing | MOONSHOTS
🔇 TAP TO UNMUTE